Trade Mark Journal No.2025/049 5 December 2025

UK00004302451 28 November 2025 (42)

28bio

International priority date claimed: 6 June 2025 (United States of America) (99222170)

Class 42: Pharmaceutical research in connection with central and peripheral nervous system diseases and disorders; providing medical and scientific research information; medical and scientific research in the field of peripheral nervous system diseases and disorders using advanced tissue engineering, neural interfacing, and artificial intelligence (AI) in relation to central and peripheral nervous system diseases and disorders; pharmaceutical, medical, and scientific research in the field of neurological function in relation to central and peripheral nervous system diseases and disorders.

AxoSim, Inc.

Representative: Barker Brettell LLP